Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) has been given an average recommendation of “Buy” by the twenty ratings firms that are currently covering the firm. One analyst has rated the stock with a sell rating, eight have given a hold rating and eleven have assigned a buy rating to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $14.82.
A number of brokerages have commented on MDRX. Cantor Fitzgerald boosted their price target on shares of Allscripts Healthcare Solutions from $12.00 to $13.00 and gave the company an “in-line” rating in a research note on Friday, February 17th. Jefferies Group LLC restated a “buy” rating and set a $16.50 price target on shares of Allscripts Healthcare Solutions in a research note on Friday, February 17th. Oppenheimer Holdings Inc. reaffirmed a “hold” rating on shares of Allscripts Healthcare Solutions in a report on Friday, February 17th. Piper Jaffray Companies cut their price objective on shares of Allscripts Healthcare Solutions from $15.00 to $14.00 and set a “neutral” rating on the stock in a report on Wednesday, March 22nd. Finally, Cowen and Company lifted their price objective on shares of Allscripts Healthcare Solutions from $12.00 to $13.00 and gave the stock a “market perform” rating in a report on Wednesday, March 22nd.
WARNING: This piece of content was originally published by Markets Daily and is the property of of Markets Daily. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this piece of content can be viewed at https://www.themarketsdaily.com/2017/04/21/allscripts-healthcare-solutions-inc-mdrx-receives-average-rating-of-hold-from-analysts-updated.html.
Allscripts Healthcare Solutions (NASDAQ:MDRX) traded down 0.59% on Friday, hitting $11.82. 746,171 shares of the company were exchanged. The stock has a 50 day moving average price of $12.16 and a 200 day moving average price of $11.69. Allscripts Healthcare Solutions has a one year low of $9.80 and a one year high of $15.17. The firm’s market cap is $2.13 billion.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its quarterly earnings results on Thursday, February 16th. The software maker reported $0.14 EPS for the quarter, missing the Zacks’ consensus estimate of $0.15 by $0.01. The business had revenue of $425.40 million for the quarter, compared to the consensus estimate of $424.11 million. Allscripts Healthcare Solutions had a negative net margin of 0.14% and a positive return on equity of 5.79%. The business’s revenue for the quarter was up 23.1% compared to the same quarter last year. During the same quarter last year, the firm posted $0.13 EPS. On average, equities research analysts forecast that Allscripts Healthcare Solutions will post $0.62 EPS for the current fiscal year.
In other Allscripts Healthcare Solutions news, SVP Brian Farley sold 15,000 shares of the company’s stock in a transaction that occurred on Thursday, March 23rd. The stock was sold at an average price of $11.63, for a total value of $174,450.00. Following the completion of the sale, the senior vice president now owns 217,861 shares of the company’s stock, valued at $2,533,723.43. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.75% of the stock is currently owned by corporate insiders.
A number of hedge funds have recently modified their holdings of the company. Sciencast Management LP purchased a new stake in shares of Allscripts Healthcare Solutions during the fourth quarter valued at about $103,000. Riverhead Capital Management LLC raised its stake in shares of Allscripts Healthcare Solutions by 63.7% in the third quarter. Riverhead Capital Management LLC now owns 8,500 shares of the software maker’s stock valued at $112,000 after buying an additional 3,308 shares in the last quarter. GSA Capital Partners LLP purchased a new stake in shares of Allscripts Healthcare Solutions during the fourth quarter valued at about $118,000. Bank of Montreal Can raised its stake in shares of Allscripts Healthcare Solutions by 60.2% in the first quarter. Bank of Montreal Can now owns 9,914 shares of the software maker’s stock valued at $126,000 after buying an additional 3,724 shares in the last quarter. Finally, Two Sigma Securities LLC purchased a new stake in shares of Allscripts Healthcare Solutions during the third quarter valued at about $134,000.
About Allscripts Healthcare Solutions
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
Receive News & Ratings for Allscripts Healthcare Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc and related companies with MarketBeat.com's FREE daily email newsletter.